Blistex Ointment
NDC Package 10157-9302-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Blistex (benzocaine and chloroxylenol) ointment is clean the affected area.Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.Children under 2 years of age: consult a physician. This formulation utilizes a ointment delivery system. Marketed by Blistex Inc., this product is identified by NDC 10157-9302 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
10157-9302-4
Package Description
1 TUBE in 1 CARTON / 28 g in 1 TUBE
Product Code
11-Digit Billing Format
10157930204
RxNorm Crosswalk
  • RxCUI: 199005 - benzocaine 5 % / chloroxylenol 0.1 % Topical Ointment
  • RxCUI: 199005 - benzocaine 0.05 MG/MG / chloroxylenol 0.001 MG/MG Topical Ointment
  • RxCUI: 213034 - Foille 5 % / 0.1 % Topical Ointment
  • RxCUI: 213034 - benzocaine 0.05 MG/MG / chloroxylenol 0.001 MG/MG Topical Ointment [Foille]
  • RxCUI: 213034 - Foille (benzocaine 5 % / chloroxylenol 0.1 % ) Topical Ointment

Clinical Specifications

Proprietary Name
Blistex Foille Medicated First Aid
Non-Proprietary Name
Benzocaine And Chloroxylenol
Substance Name
Benzocaine; Chloroxylenol
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Clean the affected area.Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.Children under 2 years of age: consult a physician.

Regulatory & Marketing

Labeler Name
Blistex Inc.
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-05-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10157-9302). Click a package code to view its specific billing and regulatory data.

1 TUBE in 1 CARTON / 14 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10157-9302-4 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Blistex Foille Medicated First Aid, a human over the counter drug labeled by Blistex Inc.. This ointment is formulated for topical use and contains benzocaine; chloroxylenol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blistex Inc. on March 05, 2013. The current certification is valid through December 31, 2026.

How is this Blistex Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10157930204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
10157-9302-4
11-Digit CMS (5-4-2)
10157-9302-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.